EP 1928494 A2 20080611 - COMBINATION THERAPY FOR IMMUNOSTIMULATION
Title (en)
COMBINATION THERAPY FOR IMMUNOSTIMULATION
Title (de)
KOMBINATIONSTHERAPIE ZUR IMMUNSTIMULATION
Title (fr)
THERAPIE COMBINEE D'IMMUNOSTIMULATION
Publication
Application
Priority
- EP 2005009383 W 20050831
- DE 102004042546 A 20040902
Abstract (en)
[origin: WO2006024518A1] The invention relates to a method for immunostimulation in a mammal, said method consisting of the following steps: a) at least one mRNA containing a region coding for at least one antigen of a pathogen or at least one tumour antigen is administered, and b) at least one cytokine, at least one cytokine-mRNA, at least one CpG DNA or at least one adjuvant RNA is administered. The invention also relates to a product and a kit containing the mRNA and cytokine or cytokine mRNA, or CpG DNA or adjuvant RNA according to the invention.
IPC 8 full level
A61K 39/39 (2006.01); A61K 38/00 (2006.01); A61K 39/00 (2006.01); A61P 35/00 (2006.01)
CPC (source: EP US)
A61K 38/1841 (2013.01 - EP US); A61K 38/19 (2013.01 - EP US); A61K 38/20 (2013.01 - EP US); A61K 38/21 (2013.01 - EP US); A61K 39/0011 (2013.01 - EP US); A61K 39/001106 (2018.08 - EP US); A61K 39/00115 (2018.08 - EP US); A61K 39/001153 (2018.08 - EP US); A61K 39/001156 (2018.08 - EP US); A61K 39/001157 (2018.08 - EP US); A61K 39/00117 (2018.08 - EP US); A61K 39/001182 (2018.08 - EP US); A61K 39/001184 (2018.08 - EP US); A61K 39/001186 (2018.08 - EP US); A61K 39/001188 (2018.08 - EP US); A61K 39/001189 (2018.08 - EP US); A61K 39/001191 (2018.08 - EP US); A61K 39/001192 (2018.08 - EP US); A61K 39/001194 (2018.08 - EP US); A61K 39/39 (2013.01 - US); A61P 25/00 (2018.01 - EP); A61P 31/00 (2018.01 - EP); A61P 31/04 (2018.01 - EP); A61P 31/12 (2018.01 - EP); A61P 33/02 (2018.01 - EP); A61P 35/00 (2018.01 - EP); A61P 37/06 (2018.01 - EP); A61P 37/08 (2018.01 - EP); A61K 2039/53 (2013.01 - US); A61K 2039/54 (2013.01 - US); A61K 2039/545 (2013.01 - US); A61K 2039/55522 (2013.01 - EP US); A61K 2039/55561 (2013.01 - EP US); A61K 2039/572 (2013.01 - US); A61K 2039/6031 (2013.01 - US); A61K 2039/70 (2013.01 - US)
C-Set (source: EP US)
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR
Designated extension state (EPC)
AL BA HR MK YU
DOCDB simple family (publication)
DE 102004042546 A1 20060309; EP 1928494 A2 20080611; US 2008025944 A1 20080131; US 2012213818 A1 20120823; US 2017000870 A1 20170105; WO 2006024518 A1 20060309
DOCDB simple family (application)
DE 102004042546 A 20040902; EP 05778932 A 20050831; EP 2005009383 W 20050831; US 201213361686 A 20120130; US 201615206488 A 20160711; US 58074605 A 20050831